DS
AERI

David Shaw’s Aerie Pharmaceuticals AERI Stock Holding History

David Shaw’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-51,900
Closed -$1.25M – 4378
2019
Q4 		$1.25M Hold
51,900
– – ﹤0.01% 2825
2019
Q3 		$998K Buy
+51,900
New +$1.19M ﹤0.01% 2833

David Shaw's AERI Position: Q4 2022 in Review

David Shaw sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 243,976 shares — an estimated $3.69M sold.

David Shaw first reported a position in AERI in Q2 2015 and held it in 12 quarters. The position peaked at $4.6M in Q3 2016. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • David Shaw reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • David Shaw sold 243,976 Aerie Pharmaceuticals shares in Q4 2022, an estimated $3.69M.
  • David Shaw first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 12 quarters.
  • David Shaw's Aerie Pharmaceuticals position peaked at $4.6M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.